Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-cou...

FDA Drug Recall #D-0816-2018 — Class II — May 11, 2018

Recall Summary

Recall Number D-0816-2018
Classification Class II — Moderate risk
Date Initiated May 11, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm L. Perrigo Company
Location Allegan, MI
Product Type Drugs
Quantity 569,520 cartons

Product Description

Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46); c) 24-count (NDC 45802-580-62), Rx only, Mfd. by: Aveva Drug Delivery Systems, A Nitto Denko Company, Miramar, FL 33025 Distributed by Perrigo, Allegan, MI 49010

Reason for Recall

Defective delivery system

Distribution Pattern

Nationwide in the U.S.A.

Lot / Code Information

Lot #: a) 46397, 46457 Exp 03/19; 46621, Exp 04/19; 46894, 46904, 46905, Exp 06/19; 47133, Exp 07/19; 47153, Exp 08/19; 47154, 47213, 47214, Exp 09/19; b) 46695, Exp 04/19; 46994, 47012, Exp 07/19; 47322 10/19; c) 46822, Exp 05/19 ; 47155, 47212, Exp 09/19

Other Recalls from L. Perrigo Company

Recall # Classification Product Date
D-0910-2023 Class II allergy relief, Fexofenadine Hydrochloride Tabl... Feb 9, 2023
D-0912-2023 Class II Allergy Relief, Fexofenadine Hydrochloride Tabl... Feb 9, 2023
D-0904-2023 Class II aller-ease, Fexofenadine Hydrochloride Tablets,... Feb 9, 2023
D-0909-2023 Class II allergyrelief, Fexofenadine Hydrochloride Table... Feb 9, 2023
D-0906-2023 Class II allergy relief, Fexofenadine Hydrochloride Tabl... Feb 9, 2023

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.